• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCR4与反向激动剂和弱部分激动剂的脂质双分子层模拟

Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists.

作者信息

Trent John O, Wang Zi-xuan, Murray James L, Shao Wenhai, Tamamura Hirokazu, Fujii Nobutaka, Peiper Stephen C

机构信息

J. G. Brown Modeling Facility, 323 Brown Cancer Center, Department of Medicine, University of Louisville, 529 S. Jackson Street, Louisville, KY 40202, USA.

出版信息

J Biol Chem. 2003 Nov 21;278(47):47136-44. doi: 10.1074/jbc.M307850200. Epub 2003 Sep 4.

DOI:10.1074/jbc.M307850200
PMID:12958314
Abstract

CXCR4 is a G protein-coupled receptor (GPCR) that has multiple critical functions in normal and pathologic physiology that include regulation of the metastatic behavior of mammary carcinoma, and utilization as a coreceptor for infection by T-tropic strains of human immunodeficiency virus-1. Molecular dynamic simulations of the rhodopsin-based homology model of CXCR4 were performed in a solvated lipid bilayer to reproduce the microenvironment of this integral membrane protein. The amino acids in CXCR4 necessary for interaction with an inverse agonist, T140, and a weak partial agonist, AMD3100, identified by alanine scanning mutants, were spatially consistent when computationally docked. Whereas T140 binds residues in extracellular domains and regions of the hydrophobic core proximal to the cell surface, amino acids in the central hydrophobic core are critical to binding of AMD3100. The physical localization of T140 binding to CXCR4 by biochemical analyses corroborated the molecular and computational approaches. The structural basis for the interaction of T140 and AMD3100 with CXCR4 confirms that the mechanisms used by these agents are different. This complementary utilization of molecular, physical, and computation analysis provides a powerful approach to elucidate GPCR conformation.

摘要

CXCR4是一种G蛋白偶联受体(GPCR),在正常和病理生理过程中具有多种关键功能,包括调节乳腺癌的转移行为,以及作为人类免疫缺陷病毒1型T嗜性毒株感染的共受体。在溶剂化脂质双层中对基于视紫红质的CXCR4同源模型进行了分子动力学模拟,以重现这种整合膜蛋白的微环境。通过丙氨酸扫描突变体鉴定出的与反向激动剂T140和弱部分激动剂AMD3100相互作用所必需的CXCR4中的氨基酸,在进行计算对接时在空间上是一致的。T140结合细胞外结构域中的残基以及靠近细胞表面的疏水核心区域,而中央疏水核心中的氨基酸对于AMD3100的结合至关重要。通过生化分析确定T140与CXCR4结合的物理定位,证实了分子和计算方法。T140和AMD3100与CXCR4相互作用的结构基础证实,这些药物所使用的机制是不同的。这种分子、物理和计算分析的互补应用提供了一种强大的方法来阐明GPCR的构象。

相似文献

1
Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists.CXCR4与反向激动剂和弱部分激动剂的脂质双分子层模拟
J Biol Chem. 2003 Nov 21;278(47):47136-44. doi: 10.1074/jbc.M307850200. Epub 2003 Sep 4.
2
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.
J Biol Chem. 2002 Jul 5;277(27):24515-21. doi: 10.1074/jbc.M200889200. Epub 2002 Mar 28.
3
Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site.光标记鉴定出CXCR4的跨膜结构域4为T140结合位点。
Biochem Pharmacol. 2009 Dec 1;78(11):1382-90. doi: 10.1016/j.bcp.2009.07.007. Epub 2009 Jul 22.
4
Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.针对AMD3100的CXCR4相互作用位点的突变会影响抗CXCR4抗体的结合以及HIV-1的进入。
FEBS Lett. 2003 Jul 10;546(2-3):300-6. doi: 10.1016/s0014-5793(03)00609-4.
5
CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins.参与人类免疫缺陷病毒1型嗜性共受体决定的CXCR4序列。用M嗜性Env糖蛋白揭示活性。
J Biol Chem. 1998 Jun 12;273(24):15007-15. doi: 10.1074/jbc.273.24.15007.
6
Identification of allosteric peptide agonists of CXCR4.CXCR4变构肽激动剂的鉴定
J Biol Chem. 2003 Jan 10;278(2):896-907. doi: 10.1074/jbc.M204667200. Epub 2002 Nov 3.
7
Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor.研究CXCR4受体变构激动剂和拮抗剂的结合相互作用。
J Mol Graph Model. 2015 Jul;60:1-14. doi: 10.1016/j.jmgm.2015.05.004. Epub 2015 May 30.
8
Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.趋化因子受体CXCR4的天冬氨酸(171)和天冬氨酸(262)发生突变会损害其作为人类免疫缺陷病毒1型进入的共受体功能,并消除AMD3100的拮抗活性。
Mol Pharmacol. 2001 Jul;60(1):164-73. doi: 10.1124/mol.60.1.164.
9
Expression of CXCR4, a G-protein-coupled receptor for CXCL12 in yeast identification of new-generation inverse agonists.CXCR4的表达,CXCL12的一种G蛋白偶联受体,用于新一代反向激动剂的酵母鉴定。
Methods Enzymol. 2009;460:399-412. doi: 10.1016/S0076-6879(09)05220-3.
10
Mapping the ligand-binding site on a G protein-coupled receptor (GPCR) using genetically encoded photocrosslinkers.利用遗传编码光交联剂绘制 G 蛋白偶联受体 (GPCR) 的配体结合位点。
Biochemistry. 2011 May 3;50(17):3411-3. doi: 10.1021/bi200214r. Epub 2011 Apr 7.

引用本文的文献

1
CXCL12 chemokine dimer signaling modulates acute myelogenous leukemia cell migration through altered receptor internalization.CXCL12趋化因子二聚体信号传导通过改变受体内化来调节急性髓性白血病细胞迁移。
Sci Rep. 2025 Jul 22;15(1):26625. doi: 10.1038/s41598-025-12005-7.
2
CXCL12 chemokine dimer signaling modulates acute myelogenous leukemia cell migration through altered receptor internalization.趋化因子CXCL12二聚体信号通过改变受体内化来调节急性髓性白血病细胞的迁移。
bioRxiv. 2024 Aug 27:2024.08.26.609725. doi: 10.1101/2024.08.26.609725.
3
Integrating deep mutational scanning and low-throughput mutagenesis data to predict the impact of amino acid variants.
整合深度突变扫描和低通量诱变数据来预测氨基酸变异的影响。
Gigascience. 2022 Dec 28;12. doi: 10.1093/gigascience/giad073. Epub 2023 Sep 18.
4
CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors.CXCR4 靶向放射性药物在恶性肿瘤的成像和治疗中的应用。
Molecules. 2023 Jun 12;28(12):4707. doi: 10.3390/molecules28124707.
5
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists.计算建模和 EPI-X4/CXCR4 复合物的实验验证,使小分子肽拮抗剂的合理设计成为可能。
Commun Biol. 2021 Sep 22;4(1):1113. doi: 10.1038/s42003-021-02638-5.
6
CXCR7 Targeting and Its Major Disease Relevance.趋化因子受体7(CXCR7)靶向作用及其与主要疾病的相关性。
Front Pharmacol. 2018 Jun 21;9:641. doi: 10.3389/fphar.2018.00641. eCollection 2018.
7
CXCR4 antagonist AMD3100 elicits analgesic effect and restores the GlyRα3 expression against neuropathic pain.趋化因子受体4(CXCR4)拮抗剂AMD3100可产生镇痛作用,并恢复甘氨酸受体α3(GlyRα3)的表达以对抗神经性疼痛。
J Pain Res. 2017 Sep 7;10:2205-2212. doi: 10.2147/JPR.S139619. eCollection 2017.
8
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.趋化因子受体4(CXCR4)抑制剂可能对人表皮生长因子受体2(HER2)阳性乳腺癌患者有益,但对三阴性乳腺癌患者无效。
Oncogene. 2017 Mar 2;36(9):1211-1222. doi: 10.1038/onc.2016.284. Epub 2016 Sep 26.
9
Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.CXCR4/CXCL12趋化因子轴在癌症药物递送中的潜力
Curr Pharmacol Rep. 2016 Feb;2(1):1-10. doi: 10.1007/s40495-015-0044-8. Epub 2016 Jan 4.
10
Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia.CXCR4趋化因子受体功能的药理学和基因破坏对B细胞急性淋巴细胞白血病的影响
Br J Haematol. 2016 Aug;174(3):425-36. doi: 10.1111/bjh.14075. Epub 2016 Apr 12.